Latest News about LEXX
Recent news which mentions LEXX
From Benzinga
From Benzinga
Lexaria Bioscience Optimistic Of Positive Study Results
February 28, 2022
Tickers
LEXX
From Benzinga
Lexaria Optimistic About Expanded DehydraTECH Investigations
February 23, 2022
Tickers
LEXX
From Benzinga
From Benzinga
From Benzinga
Lexaria Technology Shows Promise In Improving Performance Of ED Drugs
February 11, 2022
Tickers
LEXX
From Benzinga
Lexaria CEO Summarizes 2021 Milestones in Letter to Shareholders
February 09, 2022
Tickers
LEXX
From Benzinga
Lexaria CEO Offers A Glimpse Into Company's Unique Tech On EDGE Podcast
February 01, 2022
Tickers
LEXX
From Benzinga
Lexaria Bioscience Marks Great Start to its 2022 R&D Programs
January 21, 2022
Tickers
LEXX
From Benzinga
From Benzinga
Lexaria Bioscience (NASDAQ: LEXX) Receives Independent Review Board Approval for Human Study
January 11, 2022
Tickers
LEXX
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
January 07, 2022
From Benzinga
Lexaria Bioscience Increases Investor Visibility with SRAX
January 07, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 06, 2022
From Benzinga
Lexaria Bioscience Announces Approval from Independent Review for DehydraTECH-CBD Study
December 30, 2021
Tickers
LEXX
From Benzinga
Lexaria Bioscience Expects Study Results to Show Patented Tech's Value in Treating Hypertension
December 28, 2021
Tickers
LEXX
From Benzinga
Lexaria Bioscience Announces Major Discovery; Increasing Effectiveness of Orally Administered CBD
December 23, 2021
Tickers
LEXX
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.